Subscribe to
this category
r

Policy

A total of 122 posts are filed under Policy
Trump Taps Former Drug Industry Exec to Head HHS
Daniel S. Levine President Donald Trump said he would nominate Alex Azar, an attorney and former drug industry executive who served in the… Continue Reading
Health Canada Scraps Plans for Orphan Drug Framework
Health Canada has derailed a long-fought effort to establish a framework for orphan drugs. Last month the agency, without warning, removed… Continue Reading
FDA Expands Approval of Roche’s Zelboraf as First Treatment Rare Blood Cancer
Rare Daily Staff The U.S. Food and Drug Administration said it expanded the approval of Roche’s  Zelboraf to include the treatment of… Continue Reading
Ionis Submits Application to FDA to Market Antisense Drug for hATTR
Rare Daily Staff Ionis Pharmaceuticals said it submitted a new drug application to the U.S. Food and Drug Administration for inotersen, an… Continue Reading
FDA Grants Rare Pediatric Disease Designation to ArQule’s Miransertib for Proteus Syndrome
Rare Daily Staff The U.S. Food and Drug Administration granted ArQule Rare Pediatric Disease Designation for its experimental therapy… Continue Reading
FDA 2017 Orphan Drug Approvals
The following is a year-to-date list of U.S. Food and Drug Administration Orphan Drug Approvals Last update November 3, 2017… Continue Reading
Proposed Tax Bill Would Eliminate Orphan Drug Tax Credit
Rare Daily Staff The Tax Cuts and Jobs Act, a Republican proposal to make sweeping reforms to the nation’s tax code, calls for the repeal… Continue Reading
be-a-guest-blogger

Follow us on Twitter